Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

59,000

Employees59,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

59,000

Employees59,000

BSX Key Statistics

Market cap

84.96B

Market cap84.96B

Price-Earnings ratio

24.51

Price-Earnings ratio24.51

Dividend yield

—

Dividend yield—

Average volume

21.07M

Average volume21.07M

High today

$58.45

High today$58.45

Low today

$56.17

Low today$56.17

Open price

$57.75

Open price$57.75

Volume

20.67M

Volume20.67M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$56.17

52 Week low$56.17

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $56.77. The company's market cap stands at 84.96B, with a P/E ratio of 24.51.

During the trading session on 2026-04-29, Boston Scientific(BSX) shares reached a daily high of $58.45 and a low of $56.17. At a current price of $56.77, the stock is +1.1% higher than the low and still -2.9% under the high.

Trading activity shows a volume of 20.67M, compared to an average daily volume of 21.07M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $56.17.

BSX News

Simply Wall St 1h

Johnson And Johnson Trial Puts Boston Scientific Growth Story Under Scrutiny

Johnson & Johnson has launched a head to head clinical trial comparing its Varipulse Pro pulsed field ablation system with Boston Scientific's FARAPULSE platfor...

TipRanks 1d

Boston Scientific downgraded to Neutral from Outperform at Daiwa

Daiwa downgraded Boston Scientific (BSX) to Neutral from Outperform with a price target of $60, down from $83. Unlock hedge fund-level data and powerful invest...

TipRanks 7d

Boston Scientific price target lowered to $100 from $105 at RBC Capital

RBC Capital lowered the firm’s price target on Boston Scientific (BSX) to $100 from $105 and keeps an Outperform rating on the shares. The stock rose after the...

Analyst ratings

95%

of 37 ratings

Buy

94.6%

Hold

5.4%

Sell

More BSX News

Benzinga 7d

Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings

Boston Scientific Corporation (NYSE:BSX) reported upbeat earnings for the first quarter on Wednesday. The company posted first-quarter 2026 revenues of $5.20 b...

Nasdaq 7d

Company News for Apr 23, 2026

AST SpaceMobile, Inc. ( ASTS ) shares rose 5.8% after securing Federal Communications Commission approval for its satellite-based cellular broadband plan. ASTS...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.